MDPI and ACS Style
Goerg, J.; Sommerfeld, M.; Greiner, B.; Lauer, D.; Seckin, Y.; Kulikov, A.; Ivkin, D.; Kintscher, U.; Okovityi, S.; Kaschina, E.
Low-Dose Empagliflozin Improves Systolic Heart Function after Myocardial Infarction in Rats: Regulation of MMP9, NHE1, and SERCA2a. Int. J. Mol. Sci. 2021, 22, 5437.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22115437
AMA Style
Goerg J, Sommerfeld M, Greiner B, Lauer D, Seckin Y, Kulikov A, Ivkin D, Kintscher U, Okovityi S, Kaschina E.
Low-Dose Empagliflozin Improves Systolic Heart Function after Myocardial Infarction in Rats: Regulation of MMP9, NHE1, and SERCA2a. International Journal of Molecular Sciences. 2021; 22(11):5437.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22115437
Chicago/Turabian Style
Goerg, Jana, Manuela Sommerfeld, Bettina Greiner, Dilyara Lauer, Yasemin Seckin, Alexander Kulikov, Dmitry Ivkin, Ulrich Kintscher, Sergey Okovityi, and Elena Kaschina.
2021. "Low-Dose Empagliflozin Improves Systolic Heart Function after Myocardial Infarction in Rats: Regulation of MMP9, NHE1, and SERCA2a" International Journal of Molecular Sciences 22, no. 11: 5437.
https://0-doi-org.brum.beds.ac.uk/10.3390/ijms22115437